What is Muscular Dystrophy?
Müsküler distrofi, ilerleyici kas zayıflığı ve dejenerasyonu ile karakterize edilen genetik kas hastalıkları grubudur. Duchenne, Becker ve uzuv-kuşak müsküler distrofisi dahil çeşitli formları vardır.
Şu anda müsküler distrofi için kesin bir tedavi yoktur. Geleneksel yaklaşımlar fizik tedavi, ortez kullanımı ve kortikosteroidleri içerir. Rejeneratif tıp yaklaşımları, kas rejenerasyonunu destekleyerek ve hastalık ilerlemesini yavaşlatarak rejeneratif bir yaklaşım sunar.
Mezenkimal kök hücreler (MSC'ler), kas onarımını destekleyen büyüme faktörleri salgılayabilir, iltihabı azaltabilir ve potansiyel olarak kas fonksiyonunu iyileştirebilir. Bu, hastalık yönetimine tamamlayıcı bir yaklaşım sağlar.
Expert Care
Our Expert Doctors
The procedure is a minimally invasive treatment performed by our internal medicine specialists with over 20 years of practical experience.
Adult stem cells are directly injected to enhance function of organs and tissues affected by muscular dystrophy. This leads to reduced inflammation and repair of damaged tissue.
How MSC Therapy Helps With Muscular Dystrophy
MSC therapy has shown promise in slowing muscle degeneration and improving strength and mobility in MD patients through multiple mechanisms.
Reduces Inflammation
MSCs possess anti-inflammatory properties that help alleviate chronic inflammation in muscle tissues.
Promotes Muscle Repair
By differentiating into muscle and supportive cells, MSCs contribute to repairing damaged muscle fibers.
Enhanced Cellular Communication
MSCs release exosomes and cytokines that encourage cellular signaling for regeneration.
Supports Vascularization
New blood vessel formation improves oxygen and nutrient supply to muscles, crucial for recovery.
How Stem Cells Work for Muscular Dystrophy
Regenerative medicine approach for muscular dystrophy targets the progressive muscle degeneration caused by genetic mutations affecting structural proteins. Mesenchymal stem cells (MSCs) work through multiple mechanisms to support muscle fiber regeneration, reduce inflammatory damage, and activate the body's own muscle repair pathways.
MSCs activate endogenous satellite cells, the muscle-resident stem cells responsible for muscle fiber repair and regeneration. Clinical studies suggest this paracrine activation enhances the body's natural capacity to replace damaged muscle fibers with functional tissue.
Stem cells secrete anti-fibrotic factors that reduce the replacement of muscle tissue with fibrotic scar tissue. Research indicates MSCs can slow the progressive fibrosis that characterizes muscular dystrophy and preserves remaining muscle architecture.
MSCs release myogenic growth factors including IGF-1 and HGF that promote muscle cell proliferation and differentiation. Clinical observations suggest these factors support the formation of new myofibers and improve the structural integrity of existing muscle tissue.
Stem cells modulate the chronic inflammatory environment in dystrophic muscle by shifting macrophage populations from pro-inflammatory (M1) to pro-regenerative (M2) phenotypes. This immune modulation reduces ongoing muscle damage and creates conditions favorable for tissue repair.
Who Is a Good Candidate?
Regenerative medicine approach for muscular dystrophy is suitable for patients seeking regenerative support to slow disease progression and maintain functional capacity alongside their standard neuromuscular care.
Ideal Candidates
- Patients with Duchenne or Becker muscular dystrophy in early to moderate stages who still retain significant muscle function
- Individuals with limb-girdle muscular dystrophy experiencing progressive weakness seeking to preserve mobility
- Patients with facioscapulohumeral dystrophy (FSHD) wanting to slow muscle deterioration in affected regions
- Those with myotonic dystrophy seeking support for muscle wasting and functional decline
- Patients of any muscular dystrophy type who want to complement their physiotherapy and standard care with regenerative approaches
May Not Be Suitable
- Patients with end-stage muscular dystrophy with severe respiratory failure requiring full-time ventilatory support
- Individuals with advanced cardiac involvement (cardiomyopathy) requiring immediate cardiac intervention
- Patients with active systemic infections or acute rhabdomyolysis episodes
- Those unable to participate in recommended post-treatment rehabilitation and physiotherapy programs
What Results Can You Expect?
Muscle regeneration in muscular dystrophy is a gradual process. The primary goals are slowing disease progression, maintaining function, and supporting muscle repair. Results vary based on dystrophy type and stage.
Initial Recovery
Mild soreness or fatigue may occur as the body responds to treatment. Stem cells begin migrating to muscle tissue and initiating anti-inflammatory and regenerative signaling.
Early Improvements
Clinical studies suggest early improvements in muscle endurance and reduced fatigue during daily activities. Inflammatory markers such as CK levels may begin to stabilize.
Progressive Results
Measurable improvements in muscle strength assessments and functional testing are commonly observed. Many patients report improved mobility and reduced muscle cramping.
Optimal Results
Significant stabilization of muscle function with potential improvements in specific muscle groups. Physical therapy outcomes often show enhanced response and better endurance.
Long-Term Benefits
Sustained slowing of disease progression compared to expected natural decline. Many patients maintain improved functional capacity with ongoing supportive care and rehabilitation.
Individual results vary. These timelines are based on clinical observations and are not guaranteed outcomes. Your specialist will provide personalized expectations during your consultation.
Hastaların Deneyimleri
StemCell Longevita İstanbul'da rejeneratif tıbbı tercih eden hastalardan gerçek sonuçlar
"Romatoloğum iyileşmeden şaşırdı. Torunlarımın ellerini acı çekmeden tutabiliyorum — bu benim için her şey demek."
"Lupus bir on yıl boyunca hayatımı yönetti. İstanbul'daki tedaviden sonra bir ay içinde üç ülkeye seyahat ettim — bir yıl önce hayal bile edilemezdi."
How our approach Works
MSCs are harvested from allogeneic sources, prepared under strict cryopreservation methods to maintain over 97% cell viability. Treatment includes targeted injections plus IV component for systemic support.
Step 01: Kapsamlı Değerlendirme
Müsküler distrofi tipi ve şiddetinin genetik ve klinik değerlendirmesi.
Step 02: Aile Danışmanlığı
Hasta ve aile ile beklentiler ve tedavi hedeflerinin tartışılması.
Step 03: Tedavi Planlaması
Bireysel duruma ve ihtiyaçlara göre kişiselleştirilmiş protokol.
Step 04: Rejeneratif tıp yaklaşımları
Sertifikalı tesisimizde yüksek kaliteli MSC'lerin IV infüzyonu.
Step 05: Rehabilitasyon Entegrasyonu
Kas fonksiyonunu optimize etmek için fizik tedavi programıyla koordinasyon.
Safety and Standards
this approach meets the highest standards, adhering to Good Manufacturing Practice (GMP) as well as national and international health regulations.
All cells used are compliant with FDA, American Association of Tissue Banks (AATB), and Turkish Health Law guidelines to ensure patient safety and treatment efficacy.
Candidate Suitability
Not every patient with MD qualifies for MSC therapy. Our medical team thoroughly evaluates each case, reviewing medical history, current health status, and specific MD subtype. This ensures MSC therapy has potential for meaningful outcomes in quality of life.
Frequently Asked Questions
Watch Our Patient Stories & Expert Insights
See real results and hear from our medical team about stem cell therapy treatments, procedures, and patient outcomes.
Tüm Rejeneratif Tıp Uygulamaları
Çeşitli durumlar için kapsamlı rejeneratif tıp uygulamalarımızı keşfedin. Daha fazla bilgi için herhangi bir seçeneğe tıklayın.
İlgili Tedaviler
İlgili Makaleler
İlgili tedaviler ve terapiler hakkında derinlemesine araştırma makalelerimizi ve rehberlerimizi keşfedin.
Otoimmün Hastalıklar için Rejeneratif Yaklaşımlar: Araştırmalar ve Sonuçlar
Lupus, romatoid artrit ve Crohn hastalığı dahil otoimmün durumları ele almak için mezenkimal kök hücre yaklaşımlarının bağışıklık sistemini nasıl modüle ettiğine dair araştırmalar.
Makaleyi OkuRejeneratif tıp yaklaşımlarıni Anlamak: Kapsamlı Bir Rehber
Rejeneratif tıp yaklaşımlarınin bilimi, türleri, uygulamaları ve günümüzün sağlık hizmetlerinde rejeneratif tıbbın potansiyeli hakkında derin bir bakış.
Makaleyi OkuEkzosom Tedavisi: Rejeneratif Tıbbın Yeni Sınırı
Ekzosom tedavisini ve bu güçlü hücresel mesajcıların doku onarımını geliştirmek, iltihabı azaltmak ve genel gelişme süreçlerini desteklemek için nasıl kullanıldığını öğrenin.
Makaleyi OkuDünya Çapında Bu Tedavi Ne Kadar Tutar?
StemCell Longevita'daki bu rejeneratif tıp maliyetlerini diğer ülkelerdeki kliniklerle karşılaştırın.
| Ülke | Tipik Maliyet |
|---|---|
| United States | $20,000 – $35,000 |
| United Kingdom | £15,000 – £28,000 |
| Germany | €18,000 – €32,000 |
| South Korea | $15,000 – $25,000 |
| StemCell Longevita (Turkey) | €8,950'den Başlayan |
Fiyatlar, göbek kordonu kaynaklı mezenkimal kök hücre (MSC) tedavileri sunan karşılaştırılabilir kök hücre kliniklerinin piyasa araştırmasına dayanmaktadır (2025-2026). Gerçek fiyatlar klinik, hücre sayısı ve duruma göre değişiklik gösterir.